Clinical Trial Update: The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oral cyclosporine and oral lansoprazole for achieving insulin independence in individuals with Type 1 diabetes mellitus has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Perle Bioscience, Inc. | Conditions: Type 1 Diabetes | Phase 3 | Status: WITHDRAWN